Skip to main content
Premium Trial:

Request an Annual Quote

Lumera and MUSC Sign Protein Array Development Pact

NEW YORK, Feb. 6 (GenomeWeb News) - Lumera and the Medical University of South Carolina have signed a co-development agreement, Lumera said today.

 

Under the deal, MUSC researchers will work with Lumera to co-develop a new protein array based on Lumera's NanoCapture HPT technology.

 

In addition, MUSC has committed to buying Lumera's ProteomicProcessor biosensor instrument.

 

Lumera retains the commercial rights to all jointly developed intellectual property, Lumera said.

 

No further details were provided.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.